bpc-157 clinical trials human safety evidence BPC-157: What you need to know before you bpc 157 human clinical trials

People who have had gastrointestinal surgery, such as weight loss surgery, or who have digestive disorders, such as celiac disease or Crohns disease

Historically, topical formulations had a more permissive regulatory position than injectable formulations

Safety, tolerability, pharmacokinetics, and clinical outcomes following treatment of painful knee osteoarthritis with senolytic molecule UBX0101

Long-term studies in mice show that Epithalon administration significantly extended maximum lifespan by 12.3% and increased the lifespan of the last 10% of survivors by 13.3% compared to control groups, while showing no adverse effects on body weight or food consumption

These are research directions rather than confirmed benefits for tissue health, faster recovery, injury healing, or human use

It is listed as a research-only compound for analytical and experimental workflows